When animals injected with colon cancer cells subcutaneously were imaged using claudin-1 antibody conjugated LI-COR IR800DyeCW through a LI-COR Pearl Trilogy Fluorescence Imaging System, the system was able to target tumors specifically. This evidence concerns the gene CLDN1 and colonic neoplasm.